investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Understanding DNA repair pathway choice control
Daniel Durocher
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Susan L Mooberry
Taccalonolides: Mechanisms of Action and Cellular Resistance
Breast
Thomas Westbrook
Discovering Genetic Networks of Triple-Negative Breast Cancer
Breast
Jérôme Fortin
Genetic and functional dissection of PTEN tumor suppressor activity in high-grade ovarian serous carcinoma
Ovary
Ann Marie Pendergast
Kinase Target of Diverse Cell Surface Receptors in Cancer Invasion and Metastasis
Breast
Alana L Welm
Short-form Ron Kinase in Tumor Progression and Metastasis
Breast
Ankit Sinha
A novel N-glyco-proteomics driven strategy to identify tumour secreted proteins using patient-derived xenografts.
Ovary
James K Turkson
Salicylic Acid-Based Small-Molecule Stat3 Inhibitors for Anticancer Therapy
Breast
Samuel Aparicio
PP2a protein serine/threonine phosphatase mutations in cancer: functional consequences and clinical relevance
Ovary
Breast
Che-Wei Chang
Systematic identification of resistance mechanisms to HER2-targeted therapies in breast cancer.
Breast